FDA Announces Approval of Clinical Hold Guidance

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to submitting and reviewing complete responses to clinical holds, as outlined in the FDA's guidance for industry.